These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27613548)

  • 1. Are disseminated tumor cells in bone marrow and tumor-stroma ratio clinically applicable for patients undergoing surgical resection of primary colorectal cancer? The Leiden MRD study.
    Vogelaar FJ; van Pelt GW; van Leeuwen AM; Willems JM; Tollenaar RA; Liefers GJ; Mesker WE
    Cell Oncol (Dordr); 2016 Dec; 39(6):537-544. PubMed ID: 27613548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic role of disseminated tumor cells detected in peripheral blood and bone marrow of colorectal cancer.
    Wu P; Tang RN; Zou JH; Wang FC
    Hepatogastroenterology; 2012 Oct; 59(119):2164-7. PubMed ID: 23178553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study.
    Vogelaar FJ; Mesker WE; Rijken AM; van Pelt GW; van Leeuwen AM; Tanke HJ; Tollenaar RA; Liefers GJ
    BMC Cancer; 2010 Apr; 10():153. PubMed ID: 20406480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients.
    Fehm T; Banys M; Rack B; Jäger B; Hartkopf A; Taran FA; Janni W
    Int J Cancer; 2014 Feb; 134(4):925-31. PubMed ID: 23921989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.
    Hartkopf AD; Taran FA; Wallwiener M; Hahn M; Becker S; Solomayer EF; Brucker SY; Fehm TN; Wallwiener D
    Eur J Cancer; 2014 Oct; 50(15):2550-9. PubMed ID: 25096167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A perivascular niche in the bone marrow hosts quiescent and proliferating tumorigenic colorectal cancer cells.
    Möhrmann L; Zowada MK; Strakerjahn H; Siegl C; Kopp-Schneider A; Krunic D; Strunk D; Schneider M; Kriegsmann M; Kriegsmann K; Herbst F; Ball CR; Glimm H; Dieter SM
    Int J Cancer; 2020 Jul; 147(2):519-531. PubMed ID: 32077087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.
    Hinz S; Bockhorst J; Röder C; Egberts JH; Schafmayer C; Küchler T; Becker T; Kalthoff H
    Ann Surg Oncol; 2012 Aug; 19(8):2539-46. PubMed ID: 22395998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
    Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
    Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated tumor cells and their prognostic significance in nonmetastatic prostate cancer patients.
    Lilleby W; Stensvold A; Mills IG; Nesland JM
    Int J Cancer; 2013 Jul; 133(1):149-55. PubMed ID: 23280694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of disseminated tumor cells and microRNA-17-92 cluster deregulation in gastrointestinal cancer.
    Valladares-Ayerbes M; Blanco M; Haz M; Medina V; Iglesias-Díaz P; Lorenzo-Patiño MJ; Reboredo M; Santamarina I; Figueroa A; Antón-Aparicio LM; Calvo L
    Int J Oncol; 2011 Nov; 39(5):1253-64. PubMed ID: 21743960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer.
    Rahbari NN; Aigner M; Thorlund K; Mollberg N; Motschall E; Jensen K; Diener MK; Büchler MW; Koch M; Weitz J
    Gastroenterology; 2010 May; 138(5):1714-26. PubMed ID: 20100481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients.
    Rack B; Zombirt E; Trapp E; Jückstock J; Andergassen U; Neugebauer J; Kost B; Weissenbacher T; Jeschke U; Schindlbeck C; Janni W; Alunni-Fabbroni M
    Oncology; 2016; 90(4):232-8. PubMed ID: 26937631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of perineural invasion in stages II and III colorectal cancer.
    Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
    Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.
    Naume B; Synnestvedt M; Falk RS; Wiedswang G; Weyde K; Risberg T; Kersten C; Mjaaland I; Vindi L; Sommer HH; Sætersdal AB; Rypdal MC; Bendigtsen Schirmer C; Wist EA; Borgen E
    J Clin Oncol; 2014 Dec; 32(34):3848-57. PubMed ID: 25366688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated tumour cells as a prognostic biomarker in colorectal cancer.
    Flatmark K; Borgen E; Nesland JM; Rasmussen H; Johannessen HO; Bukholm I; Rosales R; Hårklau L; Jacobsen HJ; Sandstad B; Boye K; Fodstad Ø
    Br J Cancer; 2011 Apr; 104(9):1434-9. PubMed ID: 21448171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer: a pilot study.
    Hoffmann O; Aktas B; Goldnau C; Heubner M; Oberhoff C; Kimmig R; Kasimir-Bauer S
    Anticancer Res; 2011 Oct; 31(10):3623-8. PubMed ID: 21965788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
    Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
    Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience.
    Ahmed S; Fields A; Pahwa P; Chandra-Kanthan S; Zaidi A; Le D; Haider K; Reeder B; Leis A
    Clin Colorectal Cancer; 2015 Dec; 14(4):e41-7. PubMed ID: 26140732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer.
    Zhao K; Li Z; Yao S; Wang Y; Wu X; Xu Z; Wu L; Huang Y; Liang C; Liu Z
    EBioMedicine; 2020 Nov; 61():103054. PubMed ID: 33039706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.